HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dobbins, R. L. Articles by McGarry, J. D. Search for Related Content PubMed PubMed Citation Articles by Dobbins, R. L. Articles by McGarry, J. D. Social Bookmarking                What's this?

Prolonged Inhibition of Muscle Carnitine Palmitoyltransferase-1 Promotes Intramyocellular Lipid Accumulation and Insulin Resistance in Rats

From the Departments of Internal Medicine (R.L.D., L.S.S., B.B., V.E., J.M., J.D.M.) and Biochemistry (J.D.M.), University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.

Address correspondence and reprint requests to Robert L. Dobbins, MD, PhD, University of Texas Southwestern Medical Center, Dallas, TX 75235-9135. E-mail: rdobbi{at}mednet.swmed.edu .

Cross-sectional studies in human subjects have used ¹H magnetic resonance spectroscopy (HMRS) to demonstrate that insulin resistance correlates more tightly with the intramyocellular lipid (IMCL) concentration than with any other identified risk factor. To further explore the interaction between these two elements in the rat, we used two strategies to promote the storage of lipids in skeletal muscle and then evaluated subsequent changes in insulin-mediated glucose disposal. Normal rats received either a low-fat or a high-fat diet (20% lard oil) for 4 weeks. Two additional groups (low-fat + etoxomir and lard + etoxomir) consumed diets containing 0.01% of the carnitine palmitoyltransferase-1 inhibitor, R-etomoxir, which produced chronic blockade of enzyme activity in liver and skeletal muscle. Both the high-fat diet and drug treatment significantly impaired insulin sensitivity, as measured with the hyperinsulinemiceuglycemic clamp. Insulin-mediated glucose disposal (IMGD) fell from 12.57 ± 0.72 in the low-fat group to 9.79 ± 0.59, 8.96 ± 0.38, and 7.32 ± 0.28 µmol · min^-1 · 100 g^-1 in the low-fat + etoxomir, lard, and lard + etoxomir groups, respectively. We used HMRS, which distinguishes between fat within the myocytes and fat associated with contaminating adipocytes located in the muscle bed, to assess the IMCL content of isolated soleus muscle. A tight inverse relationship was found between IMGD and IMCL, the correlation (R = 0.96) being much stronger than that seen between IMGD and either fat mass or weight. In conclusion, either a diet rich in saturated fat or prolonged inhibition of fatty acid oxidation impairs IMGD in rats via a mechanism related to the accumulation of IMCL.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				D. Sebastian, L. Herrero, D. Serra, G. Asins, and F. G. Hegardt CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E677 - E686. [Abstract] [Full Text] [PDF]

				A. Tabarin, Y. Diz-Chaves, M. d. C. Carmona, B. Catargi, E. P. Zorrilla, A. J. Roberts, D. V. Coscina, S. Rousset, A. Redonnet, G. C. Parker, et al. Resistance to Diet-Induced Obesity in {micro}-Opioid Receptor-Deficient Mice: Evidence for a "Thrifty Gene" Diabetes, December 1, 2005; 54(12): 3510 - 3516. [Abstract] [Full Text] [PDF]

				I. Duivenvoorden, B. Teusink, P. C. N. Rensen, F. Kuipers, J. A. Romijn, L. M. Havekes, and P. J. Voshol Acute inhibition of hepatic {beta}-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity J. Lipid Res., May 1, 2005; 46(5): 988 - 993. [Abstract] [Full Text] [PDF]

				N. Yang, J. S. Kays, T. R. Skillman, L. Burris, T. W. Seng, and C. Hammond C75 [4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic Acid] Activates Carnitine Palmitoyltransferase-1 in Isolated Mitochondria and Intact Cells without Displacement of Bound Malonyl CoA J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 127 - 133. [Abstract] [Full Text] [PDF]

				M. Korach-Andre, J. Gao, J. S. Gounarides, R. Deacon, A. Islam, and D. Laurent Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E106 - E116. [Abstract] [Full Text] [PDF]

				E. Erol, G. W. Cline, J. K. Kim, H. Taegtmeyer, and B. Binas Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E977 - E982. [Abstract] [Full Text] [PDF]

				C. C. Bastie, T. Hajri, V. A. Drover, P. A. Grimaldi, and N. A. Abumrad CD36 in Myocytes Channels Fatty Acids to a Lipase-Accessible Triglyceride Pool That Is Related to Cell Lipid and Insulin Responsiveness Diabetes, September 1, 2004; 53(9): 2209 - 2216. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer Cardiac Metabolism as a Target for the Treatment of Heart Failure Circulation, August 24, 2004; 110(8): 894 - 896. [Full Text] [PDF]

				G. Perdomo, S. R. Commerford, A.-M. T. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, and N. F. Brown Increased {beta}-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation J. Biol. Chem., June 25, 2004; 279(26): 27177 - 27186. [Abstract] [Full Text] [PDF]

				R. Fabris, G. Mingrone, G. Milan, M. Manco, M. Granzotto, A. D. Pozza, A. Scarda, R. Serra, A. V. Greco, G. Federspil, et al. Further Lowering of Muscle Lipid Oxidative Capacity in Obese Subjects after Biliopancreatic Diversion J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1753 - 1759. [Abstract] [Full Text] [PDF]

				M. Gaster, A. C. Rustan, V. Aas, and H. Beck-Nielsen Reduced Lipid Oxidation in Skeletal Muscle From Type 2 Diabetic Subjects May Be of Genetic Origin: Evidence From Cultured Myotubes Diabetes, March 1, 2004; 53(3): 542 - 548. [Abstract] [Full Text] [PDF]

				V. B. Schrauwen-Hinderling, P. Schrauwen, M. K. C. Hesselink, J. M. A. van Engelshoven, K. Nicolay, W. H. M. Saris, A. G. H. Kessels, and M. E. Kooi The Increase in Intramyocellular Lipid Content Is a Very Early Response to Training J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1610 - 1616. [Abstract] [Full Text] [PDF]

				R. L. Dobbins, L. S. Szczepaniak, W. Zhang, and J. D. McGarry Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E778 - E787. [Abstract] [Full Text] [PDF]

				J. Kuhlmann, C. Neumann-Haefelin, U. Belz, J. Kalisch, H.-P. Juretschke, M. Stein, E. Kleinschmidt, W. Kramer, and A. W. Herling Intramyocellular Lipid and Insulin Resistance: A Longitudinal In Vivo 1H-Spectroscopic Study in Zucker Diabetic Fatty Rats Diabetes, January 1, 2003; 52(1): 138 - 144. [Abstract] [Full Text] [PDF]

				S. R. Stannard, M. W. Thompson, K. Fairbairn, B. Huard, T. Sachinwalla, and C. H. Thompson Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1185 - E1191. [Abstract] [Full Text] [PDF]

				M. J. Watt, G. J. F. Heigenhauser, and L. L. Spriet Intramuscular triacylglycerol utilization in human skeletal muscle during exercise: is there a controversy? J Appl Physiol, October 1, 2002; 93(4): 1185 - 1195. [Abstract] [Full Text] [PDF]

				C. Kohl, D. Ravel, J. Girard, and J.-P. Pegorier Effects of Benfluorex on Fatty Acid and Glucose Metabolism in Isolated Rat Hepatocytes: From Metabolic Fluxes to Gene Expression Diabetes, August 1, 2002; 51(8): 2363 - 2368. [Abstract] [Full Text] [PDF]

				P. Schrauwen, D. P.C. van Aggel-Leijssen, G. Hul, A. J.M. Wagenmakers, H. Vidal, W. H.M. Saris, and M. A. van Baak The Effect of a 3-Month Low-Intensity Endurance Training Program on Fat Oxidation and Acetyl-CoA Carboxylase-2 Expression Diabetes, July 1, 2002; 51(7): 2220 - 2226. [Abstract] [Full Text] [PDF]

				R. L. Dobbins, L. S. Szczepaniak, J. Myhill, Y. Tamura, H. Uchino, A. Giacca, and J. D. McGarry The Composition of Dietary Fat Directly Influences Glucose-Stimulated Insulin Secretion in Rats Diabetes, June 1, 2002; 51(6): 1825 - 1833. [Abstract] [Full Text] [PDF]

				R. Cazzolli, D. L. Craig, T. J. Biden, and C. Schmitz-Peiffer Inhibition of glycogen synthesis by fatty acid in C2C12 muscle cells is independent of PKC-alpha , -epsilon , and -theta Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1204 - E1213. [Abstract] [Full Text] [PDF]

				M. Haap, C. Thamer, J. Machann, O. Tschritter, K. Loblein, M. Kellerer, F. Schick, S. Jacob, H.-U. Haring, and M. Stumvoll Metabolic Characterization of a Woman Homozygous for the Ser113Leu Missense Mutation in Carnitine Palmitoyl Transferase II J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2139 - 2143. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				M. Z. Tucker and L. P. Turcotte Brief food restriction increases FA oxidation and glycogen synthesis under insulin-stimulated conditions Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1210 - R1218. [Abstract] [Full Text] [PDF]

				G. Majdic, M. Young, E. Gomez-Sanchez, P. Anderson, L. S. Szczepaniak, R. L. Dobbins, J. D. McGarry, and K. L. Parker Knockout Mice Lacking Steroidogenic Factor 1 Are a Novel Genetic Model of Hypothalamic Obesity Endocrinology, February 1, 2002; 143(2): 607 - 614. [Abstract] [Full Text] [PDF]

				J. D. McGarry Banting Lecture 2001: Dysregulation of Fatty Acid Metabolism in the Etiology of Type 2 Diabetes Diabetes, January 1, 2002; 51(1): 7 - 18. [Full Text] [PDF]

				A. V. Greco, G. Mingrone, A. Giancaterini, M. Manco, M. Morroni, S. Cinti, M. Granzotto, R. Vettor, S. Camastra, and E. Ferrannini Insulin Resistance in Morbid Obesity: Reversal With Intramyocellular Fat Depletion Diabetes, January 1, 2002; 51(1): 144 - 151. [Abstract] [Full Text] [PDF]

				O. Matzinger, P. Schneiter, and L. Tappy Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E125 - E131. [Abstract] [Full Text] [PDF]

				B. H. Goodpaster, J. He, S. Watkins, and D. E. Kelley Skeletal Muscle Lipid Content and Insulin Resistance: Evidence for a Paradox in Endurance-Trained Athletes J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5755 - 5761. [Abstract] [Full Text] [PDF]

				P. J. Voshol, M. C. Jong, V. E.H. Dahlmans, D. Kratky, S. Levak-Frank, R. Zechner, J. A. Romijn, and L. M. Havekes In Muscle-Specific Lipoprotein Lipase-Overexpressing Mice, Muscle Triglyceride Content Is Increased Without Inhibition of Insulin-Stimulated Whole-Body and Muscle-Specific Glucose Uptake Diabetes, November 1, 2001; 50(11): 2585 - 2590. [Abstract] [Full Text] [PDF]

				V. A. Zammit, I. J. Waterman, D. Topping, and G. McKay Insulin Stimulation of Hepatic Triacylglycerol Secretion and the Etiology of Insulin Resistance J. Nutr., August 1, 2001; 131(8): 2074 - 2077. [Abstract] [Full Text] [PDF]

				G. Perseghin, P. Scifo, E. Pagliato, A. Battezzati, S. Benedini, L. Soldini, G. Testolin, A. Del Maschio, and L. Luzi Gender Factors Affect Fatty Acids-Induced Insulin Resistance in Nonobese Humans: Effects of Oral Steroidal Contraception J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3188 - 3196. [Abstract] [Full Text] [PDF]